LQDA as of Oct 31 · 11:41 ET

LQDANasdaqPharmaceutical Preparations

Liquidia Corp · Brief

Next report

2 days

Nov 2 · before openest.Q3 FY26

Earnings

Expected move

Inputs

±5.5%implied · report alone

42.5847.54

straddle ±8.6%

spot 45.06exp Nov 6ATM strike 45ATM straddle 4.55IV 91%

Oct 30 closereport share · term structure

Expected move

Inputs

Implied vs realized

8 reportsHistory

2 of 8≥ implied

avg implied: ±13.2%
avg realized: ±7.4%

Nov 13 '24±7.0%▼−3.39%×0.49

Mar 19 '25±10.5%▲+1.22%×0.12

May 8 '25±9.6%▼−1.16%×0.12

Aug 12 '25±10.0%▲+13.68%×1.36

Q3 FY25±30.8%▲+3.53%×0.11

Q1 FY26±13.8%▲+0.41%×0.03

May 11 '26±12.0%▲+25.60%×2.13

Q2 FY26±11.9%▼−10.52%×0.89

quarterimplied−35%0+35%realized×

Q2 FY26±11.9%▼−10.52%×0.89

May '26±12.0%▲+25.60%×2.13

Q1 FY26±13.8%▲+0.41%×0.03

Q3 FY25±30.8%▲+3.53%×0.11

Aug '25±10.0%▲+13.68%×1.36

May '25±9.6%▼−1.16%×0.12

2 older reports

Mar '25±10.5%▲+1.22%×0.12

Nov '24±7.0%▼−3.39%×0.49

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 2 report · est.

Bull2 of 3

12disclosed supplier and customer ties in SEC filingsSEC filings

340managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

3tracked funds holding LQDAN-PORT · Aug 31 '26

26managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

LQDA report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 19impliedImplied move: ±12.4% into Nov 2 earnings (Oct 19 close).Source

Oct 148-KMaterial agreement: Settlement Agreement with United Therapeutics Corporation.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.